Company Updates Owlstone Medical raises $15 million USD (£11 million GBP) with Horizons Ventures and Aviva
Breath Biopsy Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Breath Biopsy Owlstone Medical’s disease breathalyzer, ReCIVA, to feature in Tomorrow’s World gallery at the Science Museum, London
Breath Biopsy Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease
Company Updates Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal
Company Updates Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder